{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:02Z","timestamp":1786998422053,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ygyno.2020.04.698","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T07:38:49Z","timestamp":1588232329000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["How to triage HPV positive cases: Results of four million females"],"prefix":"10.1016","volume":"158","author":[{"given":"Murat","family":"Gultekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Keskinkilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Turkyilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejat","family":"Ozgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunter","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ygyno.2020.04.698_bb0005","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ijc.31212","article-title":"Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women","volume":"142","author":"Gultekin","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.698_bb0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pvr.2019.03.002","article-title":"Mega Hpv laboratories for cervical cancer control: challenges and recommendations from a case study of Turkey","volume":"7","author":"Gultekin","year":"2019","journal-title":"Papillomavirus Res."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.698_bb0015","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.698_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.04.698_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.698_bb0030","first-page":"210","article-title":"HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers","volume":"29","author":"Dursun","year":"2013","journal-title":"Turk Patoloji Derg."},{"key":"10.1016\/j.ygyno.2020.04.698_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2334-9-191","article-title":"Human papillomavirus (HPV)prevalence and types among Turkish women at a gynecology outpatient unit","volume":"9","author":"Dursun","year":"2009","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.698_bb0040","first-page":"204","article-title":"Distribution of human papillomavirus types in Turkish women","volume":"33","author":"Tuncer","year":"2012","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.04.698_bb0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JGO.2016.006577","article-title":"Secondary prevention of cervical Cancer: ASCO resource-stratified ClinicalPractice guideline","volume":"3","author":"Jeronimo","year":"2016","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.ygyno.2020.04.698_bb0075","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"17","author":"Maver","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.ygyno.2020.04.698_bb0080","first-page":"e111","article-title":"Gynecology. Practice Bulletin No. 168: cervical cancer screening and prevention","volume":"128","author":"Committee on Practice Bulletins","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2020.04.698_bb0085","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1055-9965.EPI-19-0239","article-title":"Role of HPV genotype, multiple infections, and viral load on the risk of high-grade cervical neoplasia","volume":"28","author":"Adcock","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2020.04.698_bb0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.31390","article-title":"Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears","volume":"143","author":"Vintermyr","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.698_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ijc.31326","article-title":"Human papilloma vir\u00fcs genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more","volume":"143","author":"Del Mistro","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.698_bb0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pvr.2016.05.004","article-title":"Need for expanded HPV genotyping for cervical screening","volume":"2","author":"Cuzick","year":"2016","journal-title":"Papillomavirus Res."},{"issue":"6","key":"10.1016\/j.ygyno.2020.04.698_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.06.101","article-title":"Prior knowledge of HPV status improves detection of CIN2+ by cytology screening","volume":"205","author":"Benoy","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"42","key":"10.1016\/j.ygyno.2020.04.698_bb0110","doi-asserted-by":"crossref","first-page":"72438","DOI":"10.18632\/oncotarget.19783","article-title":"Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan","volume":"8","author":"Tshomo","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.698_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119755","article-title":"Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ygyno.2020.04.698_bb0120","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-17-0534","article-title":"Defining optimal triage strategies for hrHPV screen-positive women-an evaluation of HPV 16\/18 genotyping, cytology, and p16\/Ki-67 cytoimmunochemistry","volume":"26","author":"Stanczuk","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"12","key":"10.1016\/j.ygyno.2020.04.698_bb0125","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ijc.28900","article-title":"The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments","volume":"136","author":"Bergeron","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.698_bb0130","article-title":"Triage of HPV-positive women in Norway using cytology, HPV16\/18 genotyping and HPV persistence","volume":"3","author":"Arbyn","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.698_bb0135","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-016-2518-4","article-title":"Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study","volume":"16","author":"Preisler","year":"2016","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2020.04.698_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jasc.2019.06.001","article-title":"A review of the FDA- approved molecular testing platforms for human papillomavirus","volume":"8","author":"Salazar","year":"2019","journal-title":"J. Am. Soc. Cytopathol."},{"key":"10.1016\/j.ygyno.2020.04.698_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"10197","key":"10.1016\/j.ygyno.2020.04.698_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2020.04.698_bb0155","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10108","key":"10.1016\/j.ygyno.2020.04.698_bb0160","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: a randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.ygyno.2020.04.698_bb0165","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3201\/eid2210.160675","article-title":"Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes","volume":"22","author":"Mesher","year":"2016","journal-title":"Emerg. Infect. Dis."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820310088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820310088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:51:14Z","timestamp":1758772274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820310088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0090825820310088"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.698","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to triage HPV positive cases: Results of four million females","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}